Endocrine tumours of the pancreas

Andrew Murphy and Radswiki et al.

Endocrine tumours of the pancreas arise from the pancreatic islet cells and include some distinct tumours that match the cell type of origin. 

Pancreatic endocrine tumours have commonly been referred to as "islet cell tumours", referring to the islets of Langerhans, from which they were thought to derive. It has since been shown that these tumours derive from ductal pluripotent stem cells, and "endocrine tumour" is now preferred 3.

Most tumours are isolated. 1-2% are associated with the multiple endocrine neoplasia type I (MEN I), which is characterised by the triad of parathyroid, pituitary, and pancreatic lesions.

There are also associations between pancreatic endocrine tumours and von Hippel-Lindau and tuberous sclerosis.

Overall, pancreatic endocrine tumours have an incidence of 0.001% and account for 1-2% of pancreatic neoplasms. They occur most commonly at ages 30-60, with no clear gender predilection.

Syndromic tumours tend to present earlier, with clinical signs and symptoms related to their cell type and biological activity. 

Non-syndromic tumours tend to present later and are often larger in size.

These tumours can broadly be divided according to whether or not they secrete enough active compounds to be syndromic or not:

Individual functional tumours are discussed in more detail separately. 

The term "syndromic" is preferred over "functioning" since it is becoming increasingly clear that most tumours are functional (i.e. produce hormones), but either do not produce enough hormone or produce an ineffective variant of the hormone, so that they may not produce a clinical syndrome.

Neuroendocrine tumours are classified histologically by the presence of neurosecretory granules, which stain positively for:

  • chromogranin
  • synaptophysin
  • Gremilius stains
  • neuron-specific enolase

Overall these endocrine tumours of the pancreas tend to be highly vascular and well circumscribed, often displacing adjacent structures. They can demonstrate calcific or cystic change.

  • well-circumscribed with smooth margins
  • round or oval
  • hypoechoic

Liver metastases may be hyperechoic or targetoid.

Smaller tumours:

  • hypervascular
  • tend to be homogenous and well circumscribed

Larger tumours:

  • may appear heterogeneous and contain areas of cystic or necrotic change
  • can occasionally manifest as primarily cystic lesions and are distinguishable from other cystic neoplasms by their hypervascular rim

Since usually have a distinct capsule which means they displace rather than invade surrounding structures as they grow in size. As a result, they less frequently present with biliary obstruction, which is a classic mode of presentation for pancreatic adenocarcinomas. 

Endocrine tumours of the pancreas show peak contrast enhancement in the early arterial phase (25-35 secs) rather than in late arterial phase (35-45 secs) which is normally used for pancreatic imaging. This is particularly important when considering that small lesions may be missed in late arterial phase when the tumour will appear isointense with enhancing pancreatic parenchyma.

75% of patients with neuroendocrine tumours have metastatic disease at presentation, most commonly in the liver and less frequently in bone.

Sensitivity is similar to CT

  • T1: hypointense relative to pancreas
  • T2: typically hyperintense relative to pancreas, but there is a range of signal intensities
  • T1 C+ (Gad): hyperintense/hypervascular relative to pancreas

May be useful to localise or confirm a functioning tumour and look for metastases.

  • 111In-octreotide:
    • planar or SPECT
    • sensitivity is ~80%, although limited by the somatostatin receptor characteristics of the tumour
      • reported sensitivity is highest with gastrinomas >2 cm
      • reported sensitivity is lowest with insulinomas
    • sensitivity limited unless poorly-differentiated

If diagnosed early enough (before metastases), then complete surgical resection may be curable. Even patients with advanced disease can have reasonable long-term survival. Biological behaviour also depends on the cell of origin:

  • metastasis to the spleen (e.g. renal cell carcinoma)
  • intrapancreatic splenule (if in the tail of the pancreas)
  • mostly-solid serous cystadenoma
Pancreatic pathology
Share article

Article information

rID: 12907
Synonyms or Alternate Spellings:
  • Islet cell tumours
  • Islet cell tumour
  • Pancreatic islet cell tumours
  • Pancreatic endocrine neoplasms
  • Neuro-endocrine tumours of the pancreas
  • Neuroendocrine tumours of the pancreas
  • Pancreatic neuroendocrine tumours
  • Endocrine tumours of the pancreas
  • Pancreatic endocrine tumours
  • Pancreatic endocrine tumors
  • Islet cell tumor
  • Pancreatic endocrine tumor

Support Radiopaedia and see fewer ads

Cases and figures

  • Drag
    Case 1: OctreoScan
    Drag here to reorder.
  • Drag
    Case 1: PET-CT
    Drag here to reorder.
  • Drag
    Case 2
    Drag here to reorder.
  • Drag
    Case 4
    Drag here to reorder.
  • Drag
    Case 5: in MEN 1
    Drag here to reorder.
  • Updating… Please wait.

    Alert accept

    Error Unable to process the form. Check for errors and try again.

    Alert accept Thank you for updating your details.